Reading the tape
NYSE: HIMS
Hims & Hers Health, Inc.
Healthcare · Medical - Equipment & Services
Market Cap
$6.02B
52w High
$70.43
52w Low
$13.74
P/E
48.48
Volume
14.28M
Outstanding Shares
219.56M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -24.2%Revenue (TTM): 59%FCF (TTM): -63.26%P/FCF: 70th pct
What changed
The stock fell 24.2% over the last year. Revenue grew 59% over the trailing twelve months. Operating margin moved from 4.19% to 4.5%. Free cash flow declined 63.26% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 4.5%. A decisive move in revenue — currently up 59% — would be the clearest signal to resolve the ambiguity.
Company profile
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals.
CEOAndrew Dudum
SectorHealthcare
IndustryMedical - Equipment & Services
Employees1,637
IPO dateSep 13, 2019
Valuation
Forward P/E—
EV/EBITDA52.08
Enterprise value$8.34B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth28.41%
Gross margin73.84%▼7.07%vs FY2024
Operating margin4.5%▲7.30%vs FY2024
ROE23.73%▼10.24%vs FY2024
Analyst consensus
RatingHold
Target price$29.67▲8.25%
6
Buy
13
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 11, 2026
Q2 FY26 · EPS est $0.04 · Revenue est $616.88M
View